Different Methods of Pretreatment Ki-67 Labeling Index Evaluation in Core Biopsies of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Their Relation to Response to Therapy
Increased proliferation activity of breast cancer cells evaluated by Ki-67 immunohistochemistry, i.e. a high Ki-67 labeling index (Ki-67 LI), may predict better tumor regression in case of neoadjuvant chemotherapy. Despite recommendations for the evaluation of Ki-67 LI, there are variations in metho...
Elmentve itt :
Szerzők: |
Vörös András Csörgő Erika Kővári Bence Lázár Péter Kelemen Gyöngyi Rusz Orsolya Nyári Tibor András Cserni Gábor |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2015
|
Sorozat: | PATHOLOGY AND ONCOLOGY RESEARCH
21 No. 1 |
doi: | 10.1007/s12253-014-9800-z |
mtmt: | 2594959 |
Online Access: | http://publicatio.bibl.u-szeged.hu/18887 |
Hasonló tételek
-
Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy
Szerző: Oláh Orsolya, et al.
Megjelent: (2023) -
The prognostic value of histological grade determined after neoadjuvant chemotherapy of breast cancer
Szerző: Zombori Tamás, et al.
Megjelent: (2025) -
Changes in breast cancer grade from biopsy to excision following surgery or primary chemotherapy
Szerző: Ferenczi Ádám, et al.
Megjelent: (2024) -
An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications
Szerző: Vörös András, et al.
Megjelent: (2013) -
New approaches in the neoadjuvant systemic therapy of breast cancer
Szerző: Rusz Orsolya
Megjelent: (2018)